Research Associate I/II, Proteomics – Monte Rosa Therapeutics – Jobs in Boston, MA | OpenJobs AI

Job Details

Overview Company

Research Associate I/II, Proteomics

Monte Rosa Therapeutics

a day ago

Highlight

OnsiteFull-timeEntry

Summary

Monte Rosa Therapeutics is seeking a Research Associate I/II, Proteomics to join their team in Boston, MA. The role involves conducting experiments in proteomics for target identification of novel small molecule degraders.

About the Role

As a Research Associate I/II in Proteomics, you will be responsible for independently conducting experiments from sample preparation to data analysis and presentation of results. Your tasks will include performing quantitative proteomics experiments, preparing biological samples, executing protein biochemical techniques, and maintaining laboratory reagents. You will work collaboratively within cross-functional drug discovery teams.

About You

Required:

BSc and/or MSc in analytical chemistry, biochemistry or related field.
At least 2 years’ experience in protein mass spectrometry/proteomics in Pharma, Biotech or equivalent.
Hands-on experience with Thermo Fisher nano LC-MS instrumentation.

Preferred:

Experience in protein post-translational modification analysis, protein-protein-interaction analysis, and targeted mass spectrometry analysis.
Proficiency in culturing mammalian cells and utilizing sterile techniques.
Strong analytical and problem-solving skills.

Monte Rosa Therapeutics

Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN™ discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs.

Boston, MA